Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Phase I/II trial of a novel vaccine candidate AV-0328

April 5, 2017

Janssen Pharmaceuticals and collaborator divulge dengue virus replication inhibitors

April 5, 2017

Intralytix and BioPhage to develop topical bacteriophage treatment for S. aureus-infected wounds

April 5, 2017

Paratek reports promising topline data from phase III OPTIC study of omadacycline in CABP

April 4, 2017

XBiotech provides topline data from phase I/II study of antibody for S. aureus infections

April 4, 2017

Roche and collaborators patent anti-influenza compounds

April 4, 2017

Janssen, Katholieke Universiteit Leuven patent dengue virus replication inhibitors

April 3, 2017

Redx Pharma identifies novel antibacterial compounds

April 3, 2017

CARB-X funds projects to tackle antibiotic resistance

April 3, 2017

Takeda and MMV establish new joint research program in malaria

April 3, 2017

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...